DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



An Observational Study For Ambrisentan

Information source: GlaxoSmithKline
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypertension, Pulmonary

Intervention: ambrisentan (Drug)

Phase: N/A

Status: Completed

Sponsored by: GlaxoSmithKline

Official(s) and/or principal investigator(s):
GSK Clinical Trials, Study Director, Affiliation: GlaxoSmithKline

Summary

The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice

Clinical Details

Official title: A Post-Marketing Observational Surveillance Programme for Ambrisentan (VOLT)

Study design: Time Perspective: Prospective

Primary outcome: safety monitoring

Secondary outcome: safety monitoring

Detailed description: The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

subjects who have been prescribed ambrisentan for a medically appropriate use (see approved product label)

Locations and Contacts

GSK Investigational Site, Brussels 1070, Belgium

GSK Investigational Site, Leuven 3000, Belgium

GSK Investigational Site, Praha 2 128 08, Czech Republic

GSK Investigational Site, Praha 4 140 00, Czech Republic

GSK Investigational Site, Aarhus N DK-8200, Denmark

GSK Investigational Site, Besançon 25030, France

GSK Investigational Site, Bordeaux 33000, France

GSK Investigational Site, Brest 29200, France

GSK Investigational Site, Bron 69677, France

GSK Investigational Site, Caen Cedex 5 14033, France

GSK Investigational Site, Clamart 92140, France

GSK Investigational Site, Grenoble 38043, France

GSK Investigational Site, Lille cedex 59037, France

GSK Investigational Site, Lille 59037, France

GSK Investigational Site, Marseille cedex 20 13915, France

GSK Investigational Site, Marseille cedex 5 13385, France

GSK Investigational Site, Montpellier 34295, France

GSK Investigational Site, Nantes cedex 1 44093, France

GSK Investigational Site, Pessac cedex 33604, France

GSK Investigational Site, Poitiers cedex 86021, France

GSK Investigational Site, Reims 51092, France

GSK Investigational Site, Rennes cedex 9 35033, France

GSK Investigational Site, Rouen Cedex 76031, France

GSK Investigational Site, Strasbourg 67098, France

GSK Investigational Site, Toulouse 31059, France

GSK Investigational Site, Tours cedex 9 37044, France

GSK Investigational Site, Vandoeuvre-Les-Nancy 54511, France

GSK Investigational Site, Berlin 10117, Germany

GSK Investigational Site, Berlin 12559, Germany

GSK Investigational Site, Berlin 12683, Germany

GSK Investigational Site, Hamburg 20246, Germany

GSK Investigational Site, Alexandroupolis 68100, Greece

GSK Investigational Site, Athens 124 62, Greece

GSK Investigational Site, Thessaloniki 546 36, Greece

GSK Investigational Site, Thessaloniki 57010, Greece

GSK Investigational Site, Voula / Athens 166 73, Greece

GSK Investigational Site, Amsterdam 1081 HV, Netherlands

GSK Investigational Site, Amsterdam 1105 AZ, Netherlands

GSK Investigational Site, Groningen 9713 GZ, Netherlands

GSK Investigational Site, Maastricht 6229 HX, Netherlands

GSK Investigational Site, Nieuwegein 3435 CM, Netherlands

GSK Investigational Site, Nijmegen 6525 GA, Netherlands

GSK Investigational Site, Rotterdam 3015 CE, Netherlands

GSK Investigational Site, Bergen 5021, Norway

GSK Investigational Site, Oslo 0027, Norway

GSK Investigational Site, Bratislava 833 48, Slovakia

GSK Investigational Site, Kosice 040 11, Slovakia

GSK Investigational Site, Barcelona 08035, Spain

GSK Investigational Site, Barcelona 08036, Spain

GSK Investigational Site, Córdoba 14004, Spain

GSK Investigational Site, Madrid 28041, Spain

GSK Investigational Site, Madrid 28034, Spain

GSK Investigational Site, Malaga 29010, Spain

GSK Investigational Site, Ourense 32005, Spain

GSK Investigational Site, Pontevedra 36071, Spain

GSK Investigational Site, Sevilla 41013, Spain

GSK Investigational Site, Toledo 45004, Spain

GSK Investigational Site, Valencia 46026, Spain

GSK Investigational Site, Göteborg SE-413 45, Sweden

GSK Investigational Site, Linköping SE-581 85, Sweden

GSK Investigational Site, Lund SE-221 85, Sweden

GSK Investigational Site, Umeå SE-901 85, Sweden

GSK Investigational Site, Uppsala SE-751 85, Sweden

GSK Investigational Site, Cambridge CB3 8RE, United Kingdom

GSK Investigational Site, Clydebank G81 4DY, United Kingdom

GSK Investigational Site, London NW3 2QG, United Kingdom

GSK Investigational Site, London W12 0HS, United Kingdom

GSK Investigational Site, Newcastle upon Tyne NE7 7DN, United Kingdom

GSK Investigational Site, Sheffield S10 2JF, United Kingdom

GSK Investigational Site, Edmonton, Alberta T6G 2B7, Canada

GSK Investigational Site, Donaueschingen, Baden-Wuerttemberg 78166, Germany

GSK Investigational Site, Freiburg, Baden-Wuerttemberg 79106, Germany

GSK Investigational Site, Gerlingen, Baden-Wuerttemberg 70839, Germany

GSK Investigational Site, Heidelberg, Baden-Wuerttemberg 69120, Germany

GSK Investigational Site, Heidelberg, Baden-Wuerttemberg 69126, Germany

GSK Investigational Site, Loewenstein, Baden-Wuerttemberg 74245, Germany

GSK Investigational Site, Mannheim, Baden-Wuerttemberg 68167, Germany

GSK Investigational Site, Ulm, Baden-Wuerttemberg 89081, Germany

GSK Investigational Site, Muenchen, Bayern 81377, Germany

GSK Investigational Site, Regensburg, Bayern 93053, Germany

GSK Investigational Site, Cottbus, Brandenburg 03048, Germany

GSK Investigational Site, Treuenbrietzen, Brandenburg 14929, Germany

GSK Investigational Site, Vancouver, British Columbia V5Z 1M9, Canada

GSK Investigational Site, Napoli, Campania 80131, Italy

GSK Investigational Site, Bologna, Emilia-Romagna 40138, Italy

GSK Investigational Site, Giessen, Hessen 35392, Germany

GSK Investigational Site, Roma, Lazio 00161, Italy

GSK Investigational Site, Pavia, Lombardia 27100, Italy

GSK Investigational Site, Winnipeg, Manitoba R3A 1R8, Canada

GSK Investigational Site, Greifswald, Mecklenburg-Vorpommern 17487, Germany

GSK Investigational Site, Darlinghurst, New South Wales 2010, Australia

GSK Investigational Site, Hannover, Niedersachsen 30625, Germany

GSK Investigational Site, Aachen, Nordrhein-Westfalen 52074, Germany

GSK Investigational Site, Essen, Nordrhein-Westfalen 45122, Germany

GSK Investigational Site, Koeln, Nordrhein-Westfalen 50937, Germany

GSK Investigational Site, Moers, Nordrhein-Westfalen 47441, Germany

GSK Investigational Site, Solingen, Nordrhein-Westfalen 42699, Germany

GSK Investigational Site, Halifax, Nova Scotia B3H 3A7, Canada

GSK Investigational Site, London, Ontario N6A 5W9, Canada

GSK Investigational Site, Toronto, Ontario M5G 2N2, Canada

GSK Investigational Site, Orbassano (TO), Piemonte 10043, Italy

GSK Investigational Site, Montreal, Quebec H3T 1E2, Canada

GSK Investigational Site, Chermside, Queensland 4032, Australia

GSK Investigational Site, Mainz, Rheinland-Pfalz 55131, Germany

GSK Investigational Site, Dresden, Sachsen 01307, Germany

GSK Investigational Site, Leipzig, Sachsen 04103, Germany

GSK Investigational Site, Grosshansdorf, Schleswig-Holstein 22927, Germany

GSK Investigational Site, Luebeck, Schleswig-Holstein 23538, Germany

GSK Investigational Site, Catania, Sicilia 95100, Italy

GSK Investigational Site, Palermo, Sicilia 90127, Italy

GSK Investigational Site, Firenze, Toscana 50139, Italy

GSK Investigational Site, Pisa, Toscana 56124, Italy

GSK Investigational Site, Melbourne, Victoria 3004, Australia

Additional Information

Starting date: June 2008
Last updated: November 7, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017